Molnupiravir or nirmatrelvir-ritonavir versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby et al., medRxiv, doi:10.1101/2024.05.23.24307731
https://c19early.org/horbypl.html